Table 2.
Group | Non-Orx | Orx | Ostarine Therapy | Ostarine Proph. | Test Therapy | Test Proph. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
OC [ng/ml]§ |
174.5 | 23.9 | 207.6 | 54.3 | 123.4b,c,d | 26.8 | 138.4b,c | 26.4 | 200.4 | 32.5 | 183.2 | 31.6 |
CTX-I [ng/ml]§ |
16.7 | 3.32 | 18.1 | 4.2 | 16.6 | 1.4 | 16.9 | 4.2 | 18.8 | 2.6 | 19.6 | 2.1 |
ALP [U/l]# |
182.2 | 53.8 | 133.7 | 38.0 | 194.2 | 43.3 | 181.6 | 70.2 | 147.2 | 34.9 | 150.6 | 27.9 |
Ca [mmol/l]# |
2.17 | 0.20 | 2.06 | 0.16 | 2.03 | 0.11 | 2.16 | 0.16 | 2.21 | 0.22 | 2.28 | 0.12 |
Mg [mmol/l]# |
0.74 | 0.10 | 0.68 | 0.07 | 0.70 | 0.05 | 0.74 | 0.07 | 0.75 | 0.08 | 0.77 | 0.06 |
Phosphorus [mmol/l]# | 1.84 | 0.26 | 1.56 | 0.19 | 1.79 | 0.22 | 2.03b | 0.27 | 1.68 | 0.24 | 1.99b | 0.25 |